JEWISH GENERAL HOSPITAL

🇺🇸United States
Ownership
-
Established
1934-01-01
Employees
-
Market Cap
-
Website
http://www.jgh.ca/
Clinical Trials
Related News

Effect of Ketamine on Analgesia Post-Cardiac Surgery

First Posted Date
2016-10-06
Last Posted Date
2019-09-06
Lead Sponsor
Jewish General Hospital
Target Recruit Count
80
Registration Number
NCT02925858
Locations
🇨🇦

Jewish General Hospital, Montreal, Quebec, Canada

SUV on 68Ga-DOTATATE PET/CT and Ki-67 Index in Neuro-Endocrine Tumors

Phase 3
Completed
Conditions
Neuroendocrine Tumors
Interventions
Drug: 68Ga-DOTATATE PET/CT
First Posted Date
2016-07-21
Last Posted Date
2023-12-14
Lead Sponsor
Jewish General Hospital
Target Recruit Count
45
Registration Number
NCT02840149
Locations
🇨🇦

Jewish General Hospital, Montréal, Quebec, Canada

Apixaban in Hemodialysis

Phase 4
Completed
Conditions
End-stage Renal Disease
Interventions
Drug: apixaban
First Posted Date
2016-02-03
Last Posted Date
2016-08-30
Lead Sponsor
Jewish General Hospital
Target Recruit Count
7
Registration Number
NCT02672709
Locations
🇨🇦

Jewish General Hospital, Montreal, Canada

Randomized Controlled Trial of the Meaning-Making Intervention (MMi) In Newly Diagnosed Advanced Cancer

First Posted Date
2015-10-22
Last Posted Date
2021-01-08
Lead Sponsor
Jewish General Hospital
Target Recruit Count
179
Registration Number
NCT02583932
Locations
🇨🇦

Jewish General Hospital, Montreal, Quebec, Canada

🇨🇦

McGill University Health Centre (MUHC), Montreal, Quebec, Canada

Does Bowel Stimulation Before Loop Ileostomy Closure Reduce Postoperative Ileus?

Not Applicable
Completed
Conditions
Postoperative Ileus
Interventions
Procedure: Bowel stimulation
Drug: Nestle Resource
First Posted Date
2015-09-24
Last Posted Date
2022-08-18
Lead Sponsor
Jewish General Hospital
Target Recruit Count
101
Registration Number
NCT02559635
Locations
🇨🇦

Jewish General Hospital, Montreal, Quebec, Canada

The Use of Point-of-Care Ultrasound in the Diagnosis of Acute Infectious Mononucleosis in the Emergency Department

First Posted Date
2015-06-04
Last Posted Date
2020-10-06
Lead Sponsor
Jewish General Hospital
Target Recruit Count
200
Registration Number
NCT02463669
Locations
🇨🇦

Jewish General Hospital, Montreal, Quebec, Canada

🇨🇦

CHU Sainte-Justine, Montreal, Quebec, Canada

Loop Ileostomy With Colonic Lavage for Fulminant Clostridium Difficile Colitis

First Posted Date
2015-01-27
Last Posted Date
2019-12-20
Lead Sponsor
Jewish General Hospital
Target Recruit Count
12
Registration Number
NCT02347280
Locations
🇨🇦

Jewish General Hospital, Montreal, Quebec, Canada

Feasibility Study of a Home-based Physical Activity Intervention for Family Caregivers of People With Advanced Cancer

First Posted Date
2014-08-07
Last Posted Date
2015-03-31
Lead Sponsor
Jewish General Hospital
Target Recruit Count
28
Registration Number
NCT02211092
Locations
🇨🇦

Jewish General Hospital, Montreal, Quebec, Canada

Study of Tolerability and Safety of Adding Ustekinumab to INGAP Peptide for 12 Weeks in Adult Patients With TD1 Melitis

Phase 2
Completed
Conditions
Type 1 Diabetes Mellitus
Interventions
Drug: INGAP Peptide, Ustekinumab
First Posted Date
2014-07-30
Last Posted Date
2017-05-30
Lead Sponsor
Jewish General Hospital
Target Recruit Count
5
Registration Number
NCT02204397
Locations
🇨🇦

Montreal General Hospital, Montreal, Quebec, Canada

RNA Disruption Assay (RDA) Response Prediction in Neoadjuvant Chemotherapy Breast Cancer Treatment

Phase 2
Completed
Conditions
Invasive Breast Cancer
Interventions
Device: Tumor RDA biopsy
First Posted Date
2014-07-15
Last Posted Date
2015-02-04
Lead Sponsor
Jewish General Hospital
Target Recruit Count
30
Registration Number
NCT02190227
Locations
🇨🇦

Jewish General Hospital, Montreal, Quebec, Canada

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy